You have 8 free searches left this month | for more free features.

Tuberculosis, Multidrug-Resistant

Showing 1 - 25 of 6,787

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Strengthening Evidence on Optimal Multidrug-resistant

Recruiting
  • Tuberculosis, Multidrug-Resistant
  • HIV
  • Bdq, Lzd, Lfx, Dlm, Cfz (9-12 months)
  • +2 more
  • Almaty, Kazakhstan
  • +2 more
May 12, 2023

Tuberculosis, Multidrug-Resistant Trial (Amikacin)

Not yet recruiting
  • Tuberculosis, Multidrug-Resistant
  • (no location specified)
Sep 23, 2022

Clinical Evaluation of tNGS for Diagnosis of DR-TB

Active, not recruiting
  • Tuberculosis, Multidrug-Resistant
  • targeted Next Generation Sequencing (tNGS)
  • Tbilisi, Georgia
  • +2 more
Jan 23, 2023

Tuberculosis, Multidrug Resistant Tuberculosis Trial in Paris (Tedizolid arm (SIVEXTRO®), Linezolid arm (ZYVOXID®), Standard

Not yet recruiting
  • Tuberculosis
  • Multidrug Resistant Tuberculosis
  • Tedizolid arm (SIVEXTRO®)
  • +2 more
  • Paris, France
    Bacteriology department- Hôpital Saint-Antoine
Sep 6, 2022

Multidrug-resistant Tuberculosis

Recruiting
  • Multi-Drug Resistant Tuberculosis
    • Paris, France
      Pitié Salpêtrière Hospital
    Mar 28, 2022

    Tuberculosis, Multidrug Resistant Trial in Chernivtsi, Ivano-Frankivs'k, Kharkiv (RUTI® Therapeutic vaccine, Matching RUTI®

    Terminated
    • Tuberculosis, Multidrug Resistant
    • RUTI® Therapeutic vaccine
    • Matching RUTI® Placebo
    • Chernivtsi, Ukraine
    • +2 more
    Jun 30, 2022

    Tuberculosis, Thoracic Surgery, Tuberculosis, Pulmonary Trial in Tbilisi (therapeutical surgery for TB)

    Active, not recruiting
    • Tuberculosis
    • +3 more
    • therapeutical surgery for TB
    • Tbilisi, Georgia
      National Center for Tuberculosis and Lung Diseases
    Sep 9, 2022

    Drug-resistant Tuberculosis, HIV Coinfection, Cost-Benefit Analysis Trial in Cape Town (Targeted next-generation sequencing)

    Not yet recruiting
    • Drug-resistant Tuberculosis
    • +2 more
    • Targeted next-generation sequencing
    • Cape Town, South Africa
      South African National Health Laboratory Service
    Sep 23, 2022

    Tuberculosis, Multidrug-Resistant Trial in Dasmariñas, Hanoi (Delamanid, Levofloxacin, Bedaquiline)

    Recruiting
    • Tuberculosis, Multidrug-Resistant
    • Dasmariñas, Philippines
    • +1 more
    Jun 21, 2022

    Tuberculosis, HIV Trial in Haiti, India, South Africa (Bedaquiline)

    Recruiting
    • Tuberculosis
    • HIV Infections
    • Port-au-Prince, Haiti
    • +4 more
    Jun 15, 2022

    Pharmacometrics to Advance Novel Regimens for Drug-resistant

    Recruiting
    • Multi-drug Resistant Tuberculosis
      • Almaty, Kazakhstan
      • +6 more
      Nov 1, 2022

      Drug Resistant Tuberculosis Trial (Nurse-Led Treatment in Primary Care)

      Not yet recruiting
      • Drug Resistant Tuberculosis
      • Nurse-Led Treatment in Primary Care
      • (no location specified)
      Dec 20, 2022

      Tuberculosis, Multidrug-Resistant, Infection, Bacterial, Pulmonary Tuberculoses Trial in Worldwide (Bedaquiline, Delamanid,

      Active, not recruiting
      • Tuberculosis, Multidrug-Resistant
      • +2 more
      • Tbilisi, Georgia
      • +11 more
      Feb 14, 2022

      Tuberculosis, Multidrug-Resistant, Tuberculosis, Pulmonary Tuberculoses Trial in Worldwide (Bedaquiline 100 MG, Delamanid 50 MG

      Recruiting
      • Tuberculosis, Multidrug-Resistant
      • +5 more
      • Bedaquiline 100 MG
      • +4 more
      • Pune, India
      • +9 more
      Mar 2, 2022

      Bioneer Accupower Q-RFIA PCR Kit Clinical Evaluation

      Recruiting
      • Tuberculosis, Multidrug-Resistant
        • Nairobi, Kenya
        • +2 more
        Mar 16, 2022

        Tuberculosis, Multidrug-Resistant Trial in Cape Town (Targeted sequencing using the GenoScreen Deeplex assay)

        Not yet recruiting
        • Tuberculosis, Multidrug-Resistant
        • Targeted sequencing using the GenoScreen Deeplex assay
        • Cape Town, Western Cape, South Africa
          University of Cape Town
        Sep 28, 2021

        Tuberculosis, Pre-XDR-TB, Extensively Drug-Resistant Tuberculosis Trial in Port Elizabeth (Bedaquiline Oral Tablet, Linezolid

        Active, not recruiting
        • Tuberculosis
        • +4 more
        • Bedaquiline Oral Tablet
        • +7 more
        • Port Elizabeth, Eastern Cape, South Africa
        • +1 more
        Oct 20, 2022

        Tuberculosis Trial in Ogre, Siauliai, Vilnius (Delamanid, Optimized Background Regimen (OBR))

        Terminated
        • Tuberculosis
        • Ogre, Latvia
        • +2 more
        Oct 14, 2021

        Rifampicin Resistant Tuberculosis, Drug-resistant Tuberculosis, Multidrug Resistant Tuberculosis Trial in Bloemfontein (WGS DST

        Recruiting
        • Rifampicin Resistant Tuberculosis
        • +3 more
        • WGS DST strategy
        • Bloemfontein, Free State, South Africa
          Free State Department of Health Clinics
        Oct 14, 2021

        Expand New Drugs for TB [endTB]

        Completed
        • Tuberculosis, Multidrug-Resistant
        • This is a non-intervention observational study
        • Abovyan, Armenia
        • +15 more
        Jun 9, 2022

        Hotspots, Households and Hospitals: Enhanced Drug-resistant

        Not yet recruiting
        • Tuberculosis, Multidrug-Resistant
          • (no location specified)
          Aug 19, 2021

          Tuberculosis, MDR Trial in Kazakhstan, Kyrgyzstan (FS-1, Placebo)

          Completed
          • Tuberculosis, MDR
          • Semey, East-Kazakhstan Region, Kazakhstan
          • +5 more
          May 17, 2022

          Tuberculosis, Pulmonary, Tuberculosis, Multidrug Resistant, Extensively Drug-Resistant Tuberculosis Trial in Worldwide

          Completed
          • Tuberculosis, Pulmonary
          • +2 more
          • San Antonio, Texas
          • +16 more
          Nov 1, 2021

          Multidrug-resistant Tuberculosis, Pulmonary Tuberculosis, Tuberculosis Trial in Niamey (6EH³R³Z, 6EHRZ)

          Recruiting
          • Multidrug-resistant Tuberculosis
          • +3 more
          • Niamey, Niger
            Damien Foundation
          Oct 29, 2021

          Tuberculosis, Pulmonary, Tuberculosis, Multidrug-Resistant, Tuberculosis, MDR Trial in Johannesburg, Port Elizabeth, Rustenburg

          Recruiting
          • Tuberculosis, Pulmonary
          • +4 more
          • Johannesburg, South Africa
          • +2 more
          Oct 4, 2021